You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 202311 - 202320 of 207699 results
  1. Validation of a novel, small molecule-based osteoinductive lumbar fusion implant

    SBC: ZETAGEN THERAPEUTICS, INC.            Topic: NIAMS

    Project SummaryOverlumbar spine fusions are performed each year in the USwhich result from a number of spinal pathologies that include degenerative lumbar slipslumbar stenosisdegenerative scoliosis and fracturesIn the USan aging populationhigh smoking ratesincreasing obesityand longer life expectancy together will increase the number of lumbar spinal fusion procedures byover the next decadeSuccess ...

    SBIR Phase I 2019 Department of Health and Human ServicesNational Institutes of Health
  2. Validation of a Novel Treatment for Glioblastoma

    SBC: CURTANA PHARMACEUTICALS INC            Topic: NCI

    ? DESCRIPTION (provided by applicant): The goal of this application is to study in vivo efficacy of CT102, a newly discovered inhibitor of the OLIG2 transcription factor in animal models of glioblastoma (GBM), a highly underserved area of pharmacotherapy. In this proposal, the experienced drug discovery group at Curtana Pharmaceuticals Inc. will conduct a pre-clinical evaluation of selectivity ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Validation of a Performance Based Measure of Functioning in MCI and Early AD

    SBC: NEUROCOG TRIALS            Topic: NIA

    Project Summary Alzheimer s disease AD is expected to rise in prevalence from to million Americans by leading to of deaths among adults over This epidemic is projected to overwhelm healthcare and economic resources with costs reaching $ billion in the US in and $ trillion by There is no cure for AD and no new drugs have been successful in treating the advance ...

    SBIR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health
  4. Validation of a Performance Based Measure of Functioning in MCI and Early AD

    SBC: NEUROCOG TRIALS            Topic: NIA

    Project SummaryAlzheimer s diseaseADis expected to rise in prevalence fromtomillion Americans byleading toof deaths among adults overThis epidemic is projected to overwhelm healthcare and economic resourceswith costs reaching $billion in the US inand $trillion byThere is no cure for ADand no new drugs have been successful in treating the advanced stages of AD related dementiaA growing body of rese ...

    SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health
  5. Validation of Apnea Risk Evaluation System Sleep Scoring

    SBC: ADVANCED BRAIN MONITORING, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Obstructive Sleep Apnea (OSA) is the most common disorder observed in the practice of sleep medicine and is responsible for more mortality and morbidity than any other sleep disorder. OSA causes daytime drowsiness, and has been associated with hypertension, increased risk of congestive heart failure, coronary artery disease, myocardial infarction, cardiac arrhy ...

    SBIR Phase II 2006 Department of Health and Human ServicesNational Institutes of Health
  6. Validation of a rapid point-of-care breath test for breast cancer

    SBC: MENSSANA RESEARCH INC            Topic: NCI

    DESCRIPTIONprovided by applicantThe clinical problemBreast cancer is the commonest cancer in womenin whom it is second only to lung cancer as a cause of cancer deathMammography is the mainstay of screening for breast cancerthough its value is limited by its large number of false positive and false negative findingsA new solution the problemThe combination of two diagnostic tests with different bio ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Validation of a Rapid Progestin-Based Endocrine Disruption Screening Assay

    SBC: Fort Environmental Laboratories, Inc.            Topic: N/A

    Fort Environmental Laboratories, Inc.'s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdown ...

    SBIR Phase I 2002 Environmental Protection Agency
  8. Validation of a Rapid Progestin-Based Endocrine Disruption Screening Assay

    SBC: Fort Environmental Laboratories, Inc.            Topic: N/A

    Fort Environmental Laboratories, Inc.'s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdown ...

    SBIR Phase II 2002 Environmental Protection Agency
  9. Validation of a Rapid Progestin-Based Endocrine Disruption Screening Assay

    SBC: Fort Environmental Laboratories, Inc.            Topic: N/A

    Fort Environmental Laboratories, Inc.¿s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdow ...

    SBIR Phase I 2002 Environmental Protection Agency
  10. Validation of a Rapid Progestin-Based Endocrine Disruption Screening Assay

    SBC: Fort Environmental Laboratories, Inc.            Topic: N/A

    Fort Environmental Laboratories, Inc.¿s Phase I research project resulted in the development and standardization of an assay that tests substances that might disturb reproductive and developmental processes in animals by interfering with the endocrine system. The primary goal of the proposed research was to validate and commercialize the Xenopus laevis oocyte maturation germinal vesicle breakdow ...

    SBIR Phase II 2003 Environmental Protection Agency
US Flag An Official Website of the United States Government